IP Library Granted Patent US 7,691,565
Granted Patent B2
US 7,691,565 · App. 11/345,031 · Granted Apr 6, 2010

Binding molecules for human factor VIII and factor VIII-like proteins

Assignee: Dyax Corp.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,691,565
App. No.
11/345,031
Granted
Apr 6, 2010
Kind
B2
Abstract

It is an object of the present invention to provide novel binding molecules for factor VIII and factor VIII-like proteins. Preferred binding molecules of the present invention exhibit not only distinct characteristics for binding of the target factor VIII polypeptides but also specific and desirable characteristics for release (elution) of the target polypeptides. Especially preferred binding molecules according to the invention are short polypeptide sequences, characterized by a stable loop structure.

Claims (33)

1. A polypeptide comprising the amino acid sequence X 1 -X 2 -Cys-Ser-Trp-X 3 -X 4 -Pro-Cys-X 5 -X 6 (SEQ ID NO: 55), wherein:

X 1 is Arg or Phe;

X 2 is Leu or Gly;

X 3 is Phe;

X 4 is Ser or Phe;

X 5 is Ser or Pro; and

X 6 is Ala or Phe,

such that the polypeptide binds factor VIII.

2. The polypeptide of claim 1 , wherein X 1 is Arg, X 2 is Leu, X 4 is Ser, X 5 is Ser and X 6 is Ala.

3. The polypeptide of claim 1 , wherein a terminal amino acid residue comprises a chemical modification.

4. The polypeptide of claim 3 , wherein the carboxyl terminus comprises a chemical modification.

5. The polypeptide of claim 4 , wherein the chemical modification comprises a hydrazide functional group.

6. The polypeptide of claim 3 , wherein the amino terminus has a chemical modification.

7. The polypeptide of claim 6 , wherein the chemical modification is an acetylation.

8. A composition comprising a polypeptide comprising the amino acid sequence X 1 -X 2 -Cys-Ser-Trp-X 3 -X 4 -Pro-Cys-X 5 -X 6 (SEQ ID NO: 55), wherein:

X 1 is Arg or Phe;

X 2 is Leu or Gly;

X 3 is Phe;

X 4 is Ser or Phe;

X 5 is Ser or Pro; and

X 6 is Ala or Phe,

and wherein the polypeptide can bind factor VIII and the polypeptide is attached to a solid support matrix.

9. The composition of claim 8 wherein the polypeptide is attached to the solid support matrix via a covalent or non-covalent linkage.

10. The composition of claim 9 , wherein the solid support matrix is selected from the group consisting of: sepharose, agarose and cellulose.

11. A recombinant bacteriophage expressing exogenous DNA encoding a polypeptide, the polypeptide comprising the amino acid sequence X 1 -X 2 -Cys-Ser-Trp-X 3 -X 4 -Pro-Cys-X 5 -X 6 (SEQ ID NO: 55), wherein:

X 1 is Arg or Phe;

X 2 is Leu or Gly;

X 3 is Phe;

X 4 is Ser or Phe;

X 5 is Ser or Pro; and

X 6 is Ala or Phe;

such that the polypeptide binds factor VIII.

12. The recombinant bacteriophage of claim 11 , wherein X 1 is Arg, X 2 is Leu, X 4 is Ser, X 5 is Ser and X 6 is Ala.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2021
From: DYAX CORP.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056268/0983 →
ASSIGNMENT OF SECURITY INTEREST Recorded Oct 20, 2014
From: KGH DOMESTIC III, LP
To: VALEANT HOLDINGS IRELAND
Reel/Frame 034018/0585 →
SECURITY AGREEMENT Recorded Apr 23, 2010
From: DYAX CORP.
To: KGH DOMESTIC III, LP
Reel/Frame 024278/0531 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2009
From: YU, JINAN; POTTER, M. DANIEL; KELLEY, BRIAN D.; DEETZ, JEFFREY S.; BOOTH, JAMES E.
To: DYAX CORP.
Reel/Frame 022204/0115 →
Continuity (4)
Division 1027249700 · Oct 15, 2002
Continuation In Part 0975659400 · Jan 8, 2001
Division 0922478500 · Jan 4, 1999
Related Publication 20060193829A1 · Aug 31, 2006